Modern Immunotherapy in BCG-Unresponsive, BCG-Relapsing and High Risk BCG-Naive Non-Muscle Invasive Urothelial Carcinoma of the Bladder
Clinical trial NCT03317158 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03317158
- Sponsor
- Noah Hahn, M.D.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-21
- Primary completion
- 2028-12-31
- Enrollment
- 186
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.